Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura K Hummers

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Rheumatology (Oxford, England)|October 24, 2024
Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participantsLinda Kwakkenbos, Brooke Levis, Richard S Henry, et al.
Circulation. Heart Failure|June 26, 2013
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertensionRyan J Tedford, James O Mudd, Reda E Girgis, et al.
The Lancet. Rheumatology|August 31, 2024
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort studyGabrielle Virgili-Gervais, Bianca Matthews, Elsa-Lynn Nassar, et al.
Rheumatology (Oxford, England)|August 13, 2025
Anxiety symptoms and associated factors in the scleroderma patient-centered intervention network (SPIN) cohort: a cross-sectional studySabrina Provencher, Marie-Eve Carrier, Gabrielle Virgili-Gervais, et al.
Rheumatology (Oxford, England)|March 12, 2024
Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional studyTiffany Dal Santo, Danielle B Rice, Marie-Eve Carrier, et al.
Nature Communications|March 10, 2019
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of sclerodermaJong-Sung Park, Yumin Oh, Yong Joo Park, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
The Journal of Rheumatology|October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS RegistryVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Rheumatology (Oxford, England)|October 24, 2024
Fatigue levels and associated factors in systemic sclerosis: a cross-sectional study of 2385 SPIN Cohort participantsLinda Kwakkenbos, Brooke Levis, Richard S Henry, et al.
Circulation. Heart Failure|June 26, 2013
Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertensionRyan J Tedford, James O Mudd, Reda E Girgis, et al.
The Lancet. Rheumatology|August 31, 2024
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort studyGabrielle Virgili-Gervais, Bianca Matthews, Elsa-Lynn Nassar, et al.
Rheumatology (Oxford, England)|August 13, 2025
Anxiety symptoms and associated factors in the scleroderma patient-centered intervention network (SPIN) cohort: a cross-sectional studySabrina Provencher, Marie-Eve Carrier, Gabrielle Virgili-Gervais, et al.
Rheumatology (Oxford, England)|March 12, 2024
Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional studyTiffany Dal Santo, Danielle B Rice, Marie-Eve Carrier, et al.
Nature Communications|March 10, 2019
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of sclerodermaJong-Sung Park, Yumin Oh, Yong Joo Park, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Current Respiratory Medicine Reviews|November 17, 2015
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)Shikha Mittoo, Sid Frankel, Daphne LeSage, et al.
The Journal of Rheumatology|October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS RegistryVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Pageof 14